4/10
08:05 am
plrx
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
Medium
Report
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
4/10
06:43 am
plrx
Rating for PLRX
Medium
Report
Rating for PLRX
4/10
06:43 am
plrx
Rating for PLRX
Medium
Report
Rating for PLRX
3/12
12:38 pm
plrx
Rating for PLRX
Low
Report
Rating for PLRX
3/12
12:38 pm
plrx
Rating for PLRX
Low
Report
Rating for PLRX
3/5
10:25 am
plrx
Rating for PLRX
Low
Report
Rating for PLRX
3/5
10:25 am
plrx
Rating for PLRX
Low
Report
Rating for PLRX
2/28
01:10 pm
plrx
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $48.00 price target on the stock.
Report
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $48.00 price target on the stock.
2/28
10:26 am
plrx
Rating for PLRX
Medium
Report
Rating for PLRX
2/28
10:26 am
plrx
Rating for PLRX
Medium
Report
Rating for PLRX
2/28
08:18 am
plrx
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
Medium
Report
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
2/28
05:27 am
plrx
Rating for PLRX
Medium
Report
Rating for PLRX
2/28
05:27 am
plrx
Rating for PLRX
Medium
Report
Rating for PLRX
2/5
01:53 pm
plrx
Rating for PLRX
Low
Report
Rating for PLRX
2/5
01:53 pm
plrx
Rating for PLRX
Low
Report
Rating for PLRX